http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100267059-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7c27b9ec61781656e6f039702fd568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d51a565e0a6d7bd7d971f80f3dae0441
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-42
filingDate 1998-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a4189414d35bfe00d16d7d1c948ead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f89ba6009a6be5adaec5b4376f03b4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80df78e610e620ef2fb46738fb8ff78d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c99a93a6a6252ae312800928150a4088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6cf9c971b7955694c950d086cd77469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab15980cb6b6392242aa8b269a58d051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b93ae808ac831b8a3a51334131b4ca82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2a6f4c420c78f90a420d5137218905f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d7cbc76d45fe65443181605d28e681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14e834327e88f68a0aa1e7100ca5f543
publicationDate 2000-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100267059-B1
titleOfInvention 3-vinylquinoline derivatives and pharmaceutically acceptable salts thereof
abstract The present invention relates to a quinoline derivative having a vinyl substituent at position 3 represented by the following formula (1), a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition containing the same as an active ingredient, and 3-vinyl of the present invention. Since quinoline derivatives and salts thereof have a function of inhibiting gastric acid secretion in mammals, they may be usefully used as therapeutic agents for gastric ulcers.n n n n n n n n n n In Formula 1, R 1 , R 2 , Ar, X, and n are as defined in the specification.
priorityDate 1998-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457308642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11435064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432208158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451149986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142638141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426511559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11324649

Total number of triples: 74.